Hasbro, Sarepta Therapeutics, Akari Therapeutics News Today

Hasbro, Sarepta Therapeutics, and Akari Therapeutics stocks are in the news today

Apr 24, 2017 at 9:59 AM
facebook X logo linkedin

Stocks are soaring today in reaction to the results from the French presidential election. Among specific names in focus are toymaker Hasbro, Inc. (NASDAQ:HAS), as well as drugmakers Sarepta Therapeutics Inc (NASDAQ:SRPT) and Akari Therapeutics PLC (ADR) (NASDAQ:AKTX). Here's a quick roundup of the news moving shares of HAS, SRPT, and AKTX.

Hasbro Stock Hits New Highs After Earnings

Unlike rival Mattel, Inc. (NASDAQ:MAT), HAS stock is trading up 6.3% at $102.06 -- and earlier hit a record high of $104.14 -- after the company reported better-than-expected earnings on strong demand for "Nerf" and "Transformer" toys. Heading into today's trading, the stock had recently established a foothold in the $95-$96 region, home to its early February post-bull gap highs. Now, Hasbro, Inc. shares are up 30% year-to-date, and a round of well-deserved upgrades could draw more buyers to the table. Currently all six of the analysts covering HAS stock maintain a tepid "hold" recommendation.

Barron's Thinks Sarepta Therapeutics Stock Could Double

SRPT was featured in a bullish Barron's write-up over the weekend, with the financial news publication waxing optimistic over a possible buyout bid for its Duchenne muscular dystrophy, or DMD, treatment. What's more, the article said SRPT stock could "double or more," and that it's "an attractive play on a biotech drug with large sales potential and less risk following the [Food and Drug Administration] approval last year" (subscription required). At last check, SRPT stock was trading 3.6% higher at $33.80, bringing its 2017 advance to 23%. Options traders, meanwhile, have been busy buying to open calls over puts on Sarepta Therapeutics Inc. The stock's 10-day call/put volume ratio of 12.61 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) ranks in the 99th annual percentile. Thursday afternoon, SRPT will report first-quarter earnings.

Akari Therapeutics Stock Reverses Sharply as Coversin Data Hits

AKTX stock was higher in pre-market trading, as positive mid-stage trial results for the company's blood disorder drug, Coversin, hit the Street. However, the shares have since reversed on a possible "sell the news" scenario, and were last seen down 9.5% at $18.55. Nevertheless, the stock is still up over 160% year-to-date -- due in large part to a late-March bull gap after Coversin received fast-track status at the FDA. Short sellers have jumped ship in recent weeks, with short interest down 15.6% in the most recent reporting period. These bearish bets now account for just 0.4% of Akari Therapeutics PLC's available float.

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls



Rainmaker Ads CGI